SEARCH
Search Details
SHIMA FumiGraduate School of Science, Technology and Innovation / Department of Science, Technology and InnovationProfessor
Research activity information
■ Award■ Paper
- ABSTRACT A severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection causes mild-to-severe respiratory symptoms, including acute respiratory distress. Despite remarkable efforts to investigate the virological and pathological impacts of SARS-CoV-2, many of the characteristics of SARS-CoV-2 infection still remain unknown. The interferon-inducible ubiquitin-like protein ISG15 is covalently conjugated to several viral proteins to suppress their functions. It was reported that SARS-CoV-2 utilizes its papain-like protease (PLpro) to impede ISG15 conjugation, ISGylation. However, the role of ISGylation in SARS-CoV-2 infection remains unclear. We aimed to elucidate the role of ISGylation in SARS-CoV-2 replication. We observed that the SARS-CoV-2 nucleocapsid protein is a target protein for the HERC5 E3 ligase-mediated ISGylation in cultured cells. Site-directed mutagenesis reveals that the residue K374 within the C-terminal spacer B-N3 (SB/N3) domain is required for nucleocapsid-ISGylation, alongside conserved lysine residue in MERS-CoV (K372) and SARS-CoV (K375). We also observed that the nucleocapsid-ISGylation results in the disruption of nucleocapsid oligomerization, thereby inhibiting viral replication. Knockdown of ISG15 mRNA enhanced SARS-CoV-2 replication in the SARS-CoV-2 reporter replicon cells, while exogenous expression of ISGylation components partially hampered SARS-CoV-2 replication. Taken together, these results suggest that SARS-CoV-2 PLpro inhibits ISGylation of the nucleocapsid protein to promote viral replication by evading ISGylation-mediated disruption of the nucleocapsid oligomerization. IMPORTANCE ISG15 is an interferon-inducible ubiquitin-like protein that is covalently conjugated to the viral protein via specific Lys residues and suppresses viral functions and viral propagation in many viruses. However, the role of ISGylation in SARS-CoV-2 infection remains largely unclear. Here, we demonstrated that the SARS-CoV-2 nucleocapsid protein is a target protein for the HERC5 E3 ligase-mediated ISGylation. We also found that the residue K374 within the C-terminal spacer B-N3 (SB/N3) domain is required for nucleocapsid-ISGylation. We obtained evidence suggesting that nucleocapsid-ISGylation results in the disruption of nucleocapsid-oligomerization, thereby suppressing SARS-CoV-2 replication. We discovered that SARS-CoV-2 papain-like protease inhibits ISG15 conjugation of nucleocapsid protein via its de-conjugating enzyme activity. The present study may contribute to gaining new insight into the roles of ISGylation-mediated anti-viral function in SARS-CoV-2 infection and may lead to the development of more potent and selective inhibitors targeted to SARS-CoV-2 nucleocapsid protein.American Society for Microbiology, Sep. 2024, Journal of Virology, 98(9) (9), EnglishScientific journal
- GTP-bound forms of Ras proteins (Ras•GTP) assume two interconverting conformations, "inactive" state 1 and "active" state 2. Our previous study on the crystal structure of the state 1 conformation of H-Ras in complex with guanosine 5'-(β, γ-imido)triphosphate (GppNHp) indicated that state 1 is stabilized by intramolecular hydrogen-bonding interactions formed by Gln61. Since Ras are constitutively activated by substitution mutations of Gln61, here we determine crystal structures of the state 1 conformation of H-Ras•GppNHp carrying representative mutations Q61L and Q61H to observe the effect of the mutations. The results show that these mutations alter the mode of hydrogen-bonding interactions of the residue 61 with Switch II residues and induce conformational destabilization of the neighboring regions. In particular, Q61L mutation results in acquirement of state 2-like structural features. Moreover, the mutations are likely to impair an intramolecular structural communication between Switch I and Switch II. Molecular dynamics simulations starting from these structures support the above observations. These findings may give a new insight into the molecular mechanism underlying the aberrant activation of the Gln61 mutants.Elsevier BV, Aug. 2021, Biochemical and Biophysical Research Communications, 565, 85 - 90, English, International magazine[Refereed]Scientific journal
- Sep. 2018, Biochemistry, 57(36) (36), 5350 - 5358, EnglishMolecular Basis for Allosteric Inhibition of GTP-Bound H-Ras Protein by a Small-Molecule Compound Carrying a Naphthalene Ring.[Refereed]Scientific journal
- Dec. 2017, CANCER LETTERS, 410, 82 - 91, English[Refereed]Scientific journal
- Oct. 2017, JOURNAL OF MOLECULAR GRAPHICS & MODELLING, 77, 51 - 63, English[Refereed]Scientific journal
- Oct. 2016, CANCER DISCOVERY, 6(10) (10), 1148 - 1165, English[Refereed]Scientific journal
- May 2016, SCIENTIFIC REPORTS, 6, 25931, English[Refereed]Scientific journal
- May 2013, PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 110(20) (20), 8182 - 8187, English[Refereed]Scientific journal
- 2013, Enzymes, 34, 1 - 23, English[Refereed]Scientific journal
- 2013, SPring-8 Research Frontiers, EnglishStructure-based drug design of small-molecule Ras inhibitors having anti-tumor activity[Refereed][Invited]Research institution
- Jun. 2012, FEBS LETTERS, 586(12) (12), 1715 - 1718, English[Refereed]Scientific journal
- Nov. 2011, JOURNAL OF BIOLOGICAL CHEMISTRY, 286(45) (45), 39644 - 39653, English[Refereed]Scientific journal
- Apr. 2011, JOURNAL OF BIOLOGICAL CHEMISTRY, 286(17) (17), 15403 - 15412, English[Refereed]Scientific journal
- Jul. 2010, JOURNAL OF BIOLOGICAL CHEMISTRY, 285(29) (29), 22696 - 22705, English[Refereed]Scientific journal
- Apr. 2009, BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 381(3) (3), 439 - 442, English[Refereed]Scientific journal
- May 2008, BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 369(2) (2), 327 - 332, English[Refereed]Scientific journal
- Sep. 2005, JOURNAL OF BIOLOGICAL CHEMISTRY, 280(35) (35), 31267 - 31275, English[Refereed]Scientific journal
- Jun. 2005, SEIKAGAKU, 77(6) (6), 519 - 526, JapaneseCritical role of posttranslational modification of Ras proteins in effector activation[Refereed]Scientific journal
- 2004, Kobe Journal of Medical Sciences, 50(3-4) (3-4), 111 - 121, English[Refereed]Scientific journal
- Feb. 2002, JOURNAL OF BIOLOGICAL CHEMISTRY, 277(5) (5), 3117 - 3123, English[Refereed]Scientific journal
- May 2000, BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 271(3) (3), 596 - 602, EnglishRole of Raf-1 conserved region 2 in regulation of Ras-dependent Raf-1 activation[Refereed]Scientific journal
- American Society for Microbiology, 2000, Molecular and Cellular Biology, 20(1) (1), 26 - 33, EnglishScientific journal
- Apr. 1999, BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 257(1) (1), 111 - 116, EnglishCharacterization of a novel Ras-binding protein Ce-FLI-1 comprising leucine-rich repeats and gelsolin-like domains[Refereed]Scientific journal
- Oct. 1998, Journal of Biological Chemistry, 273(43) (43), 28019 - 28024, English[Refereed]Scientific journal
- Mar. 1998, JOURNAL OF BIOLOGICAL CHEMISTRY, 273(11) (11), 6218 - 6222, EnglishIdentification of PLC210, a Caenorhabditis elegans phospholipase C, as a putative effector of Ras[Refereed]Scientific journal
- American Society for Microbiology, 1997, Molecular and Cellular Biology, 17(3) (3), 1057 - 1064, EnglishScientific journal
- Mar. 1996, JOURNAL OF BIOLOGICAL CHEMISTRY, 271(10) (10), 5353 - 5360, EnglishDifferential structural requirements for interaction of Ras protein with its distinct downstream effectors[Refereed]Scientific journal
- Feb. 2020, BIOPHYSICAL JOURNAL, 118(3) (3), 42A - 42A, EnglishNovel Insights into the Structural Perturbation Induced by the Oncogenic Mutations, Q61L and Q61H, in Ras State 1Summary international conference
- 2020, 日本分子生物学会年会プログラム・要旨集(Web), 43rdSACLA,SPring-8並びにNMRを用いた低分子量Gタンパク質RasのGTP加水分解過程における動的構造解析
- Aug. 2015, JOURNAL OF BIOCHEMISTRY, 158(2) (2), 91 - 99, English[Refereed]Book review
- 日本放射光学会, 2014, 日本放射光学会誌 放射光, 27(1) (1), 3 - 9, Japaneserasがん遺伝子産物の新規立体構造情報を利用した分子標的がん治療薬の開発[Refereed]Introduction scientific journal
- Jun. 2005, 生化学, 77巻, 6号, pp.519-526, Japanese【タンパク質修飾による機能変化】 エフェクター活性化過程に必須であるRasの翻訳後修飾 Ras-エフェクター相互作用の高次構造解析Introduction scientific journal
- 01 Aug. 1996, 日本分子生物学会年会プログラム・講演要旨集, 19, 314 - 314, Japaneseシクラーゼ結合蛋白質CAPは, Ras蛋白質の翻訳後修飾の出芽酵母アデニル酸シクラーゼ活性化促進効果に必須である.
- 1996, J. Biol. Chem., 271(10) (10), 5353 - 5360
- Joint work, がん分子標的治療, 2015, Japaneseras がん遺伝子産物 Ras を分子標的としたがん治療薬開発の現状General book
- Joint work, 日本生化学会, Jun. 2005, Japanese生化学 / エフェクター活性化過程に必須であるRasの翻訳後修飾Scholarly book
- 第46回日本分子生物学会年会, Dec. 2023, JapaneseRecognition mechanism of conformational states in RAS by GTPase-acting protein,GAPPoster presentation
- The 96th Annual Meeting of the Japanese Biochemical Society, Oct. 2023, JapaneseInactivation mechanism og RASelucidated by photoreactive GTPOral presentation
- THE 82ND ANNUAL MEETING OF THE JAPANESE CANCER ASSOCIATION, Sep. 2023, JapaneseRAS-signaling inhibitors that allosterically disrupt effector conformation and inhibit growth of RAS-driven cancersOral presentation
- 第95回日本生化学会大会, Nov. 2022, Japanese低分子量Gタンパク質H-Rasのフリーズトラップ結晶構造解析によるGTPase活性分子メカニズムの追跡Poster presentation
- 第95回日本生化学会大会, Nov. 2022, JapaneseSACLA/SPring-8/NMRを駆使した低分子量G蛋白質Rasの不活性化機構におけるアロステリック構造変化の解明Poster presentation
- 第5回徳島大学統合的がん創薬研究クラスター・合同オンラインミーティング, Mar. 2022, JapaneseSACLA/SPring-8/NMRを用いたRasのアロステリック構造変化の解明
- 第94回日本生化学会大会, Nov. 2021Confoemational changes neighboring the GTP-binding site of small GTPase Ras upon GTP hydrolysis process.Poster presentation
- 第94回日本生化学会大会, Nov. 2021, JapaneseVisualization of enzyme-catalyezed reaction of oncogene product Ras utilizing its photo-reactive substrateInvited oral presentation
- 第43回日本分子生物学会年会, Dec. 2020, EnglishAnalysis of conformational dynamics of small G-proten Ras on GTP hydrolysis process by SACLA,Spring-8 and NMRPoster presentation
- 第33回日本放射光学会年会・放射光科学合同シンポジウム, Jan. 2020-
- 第3回徳島大学統合的がん創薬研究クラスター合同ミーティング, Dec. 2019-[Invited]
- 第57回日本生物物理学会年会, Sep. 2019, Japanese, Domestic conferenceStructural changes on GTP hydrolysis of oncogene product Ras revealed by SACLA, Spring-8 and NMR using photo-controllable caged-GTPPoster presentation
- 第2回徳島大学統合的がん創薬研究クラスター合同ミーティング, Feb. 2019, 徳島大学統合的がん創薬研究クラスター, 淡路夢舞台 国際会議場構造生物学に基づくがん治療薬の創出研究[Invited]
- 第41回日本分子生物学会年会, Nov. 2018, 日本分子生物学会年会, パシフィコ横浜Conformational dynamics of small GTPase Ras on GTP hydrolysis process revealed by SACLA, Spring-8 and NMRPoster presentation
- 第56回日本生物物理学会年会, Sep. 2018, 日本生物物理学会, 岡山大学 津島キャンパスConformational changes on GTP hydrolysis of oncogene product Ras revealed by monitoring of time-dependent NMR signal using caged-GTP
- 2017年度生命科学系学会合同年次大会(第40回日本分子生物学会年会 第90回日本生化学会大会), Dec. 2017, Japanese, 日本分子生物学会日本生化学会, 神戸, Domestic conferenceNovel effect of Ras inhibitor and its application to cancer therapyPoster presentation
- 第76回 日本癌学会学術総会, Sep. 2017, Japanese, 日本癌学会, 横浜, International conferenceRas inhibitors display anti-metastatic effect toward ras-transformed cancer cells via downregulation of lysyl oxidaseOral presentation
- University of Washington-Kobe University Joint Symposium on Cell Signaling, Sep. 2015, English, University of Washington and Kobe University, Seattle, USA, International conferenceIn silico discovery of small-molecule Ras inhibitors[Invited]Invited oral presentation
- 2015 Annual Meeting of the American Crystallographic Association, Jul. 2015, English, American Crystallographic Association, Philadelphia, USA, International conferenceCrystal Mounting Method using Humid Air and Hydrophilic Glue Coating For Ambient and Cryogenic ExperimentsOral presentation
- 第15回日本蛋白質科学会年会, Jun. 2015, Japanese, 日本蛋白質科学会, 徳島, Domestic conference試料雰囲気湿度調整によるRasタンパク質の結晶内構造転移Poster presentation
- 第15回日本蛋白質科学会年会, Jun. 2015, Japanese, 日本蛋白質科学会, 徳島, Domestic conferenceGTP結合型H-RasのState 1結晶構造情報に基づく立体構造遷移機構の解明Poster presentation
- 創薬支援ネットワーク・シンポジウム「オールジャパンの創薬支援」創薬立国日本に向けて, Jan. 2015, Japanese, 創薬支援ネットワーク・医薬基盤研究所 創薬支援戦略室, 大阪, Domestic conference創薬支援ネットワークの支援を受けて[Invited]Invited oral presentation
- 第72回日本癌学会学術総会, Oct. 2013, English, 日本癌学会, 横浜, Domestic conferenceAnalysis of the mechanism underlying the anti-metastatic action of Ras inhibitors by using a lung metastatic model mousePoster presentation
- BMB2010 (第33回日本分子生物学会年回・第83回日本生化学会大会合同大会), Dec. 2010, Japanese, 日本生化学会大会/日本分子生物学会, 神戸, Domestic conferenceMolecular mechanism of conformational transition of GTP-bound Ras revealed by the crystal structure analysis of M-Ras mutantsPoster presentation
- 第33回日本分子生物学会年会, Dec. 2010, Japanese, 日本分子生物学会, 神戸, Domestic conferenceGTP結合型M-Ras変異体の二種類の結晶構造から考察される立体構造遷移メカニズムOral presentation
- 第69回日本癌学会学術総会, Sep. 2010, Japanese, 日本癌学会, 大阪, Domestic conferenceNew strategy for development of anti-cancer drugs targeting the ras oncogene productsInvited oral presentation
- 第32回日本分子生物学会年会, Dec. 2009, Japanese, 日本分子生物学会, 横浜, Domestic conferenceGTP結合型Rasの構造遷移における分子メカニズムの解析Poster presentation
- 第82回日本生化学会大会, Oct. 2009, Japanese, 日本生化学会, 神戸, Domestic conferenceX-ray crystal structure analysis of the budding yeast small GTPase Ras2Poster presentation
- 「G蛋白質シグナル」研究班会議, Sep. 2009, Japanese, 文部科学省特定領域研究, 千葉県・南房総市, Domestic conferenceGTP結合型Rasの構造遷移メカニズムと創薬への応用Others
- 神戸大学グローバルCOEプログラム「統合的膜生物学の国際教育研究拠点」 第3回ワークショップ, Jul. 2009, Japanese, 神戸大学/グローバルCOE, 淡路, Domestic conferenceStructural analysis of the novel state1 conformation of Ras proteinPoster presentation
- G蛋白質特定領域・膜輸送複合体特定領域合同若手ワークショップ 2009, Jan. 2009, Japanese, 文部科学省特定領域研究, 神戸, Domestic conferenceGTP結合型Rasの立体構造多型性と創薬への応用Oral presentation
- G蛋白質特定領域・膜輸送複合体特定領域合同若手ワークショップ 2009, Jan. 2009, Japanese, 文部科学省特定領域研究, 神戸, Domestic conferenceGTP結合型M-Rasの構造遷移におけるH-Ras型アミノ酸置換の影響Oral presentation
- G蛋白質特定領域・膜輸送複合体特定領域合同若手ワークショップ 2009, Jan. 2009, Japanese, 文部科学省特定領域研究, 神戸, Domestic conferenceGTP結合型H-Rasの立体構造多型性とエフェクター新規認識機構Oral presentation
- Kobe University Global COE Program International Symposium on Integrative Membrane Biology, Dec. 2008, English, グローバルCOE, 神戸, Domestic conferenceScreening for Ras specific inhibitors based on the conformational equilibrium of Ras in complex with GTPPoster presentation
- 特定研究領域「G蛋白質シグナル」研究班会議, Sep. 2008, Japanese, 特定研究領域「G蛋白質シグナル」, 新潟, Domestic conferenceGTP結合型H-Rasの高次構造多型性とエフェクターの新規認識機構Poster presentation
- 第3回グローバルCOE研究討論会 兼グローバルCOE第2回ワークショップ, Jul. 2008, Japanese, グローバルCOE, 淡路, Domestic conferenceNew strategy to develop Ras specific inhibitors based on conformational equilibrium of Ras oncoprotein.Poster presentation
- 第3回グローバルCOE研究討論会 兼グローバルCOE第2回ワークショップ, Jul. 2008, Japanese, グローバルCOE, 淡路, Domestic conferenceNew strategy to develop Ras specific inhibitorsPoster presentation
- BMB2007第30回日本分子生物学会年会、第80回日本生化学会大会合同大会, Dec. 2007, Japanese, 日本分子生物学会/日本生化学会, 横浜, Domestic conferenceConformational equilibrium of small GTPases and signal transductionPoster presentation
- 2007InternationalSymposiumon“G-proteinSignaling”, Jul. 2007, English, The Japanese Grant-in-Aid for Scientific Research on Priority Areas: “G-protein signal” 文部科学省特定領域研究「G蛋白質シグナル」, 東京, International conferenceNew strategy to develop Ras specific inhibitors based on conformational equilibrium of Ras oncoprotein[Invited]Invited oral presentation
- 第66回神戸バイオサイエンス研究会, May 2007, Japanese, 神戸バイオサイエンス研究会, 神戸, Domestic conferenceRasをターゲットにした抗癌剤のインシリコ創薬Invited oral presentation
- 日本分子生物学会2006フォーラム「分子生物学の未来」〜コンファレンス&サイエンティフィック・エキジビション〜, Dec. 2006, English, 日本分子生物学会, 名古屋, Domestic conferenceGTP Dissociation Rate and Conformational Equilibrium in Various Small GTPasesPoster presentation
- 神戸大学21世紀COEプログラム「蛋白質のシグナル伝達機能」 平成18年度第1回研究発表会・若手ポスター発表会, Aug. 2006, Japanese, 神戸大学21世紀COEプログラム「蛋白質のシグナル伝達機能」, 神戸, Domestic conferenceSignal transduction and conformational equilibrium in various small GTP-binding proteinsPoster presentation
- 20th IUBMB International Congress of Biochemistry and Molecular Biology and 11th FAOMBM Congress,第79回日本生化学会大会、第29回日本分子生物学会年会, Jun. 2006, English, The International Union of Biochemistry and Molecular Biology/The The Federation of Asian and Oceanian Biochemists and Molecular Biologists /日本生化学会/日本分子生物学会, 京都, International conferenceAllostery in effector recognition by Ras family small GTPases: conformational transition in the GTP-bound formPoster presentation
- Keystone Symposia, Frontiers in Structural Biology, Jan. 2006, English, Keystone Symposia, キーストン, International conferenceCrystal structure of M-Ras reveals a GTP-bound "off" state conformation of Ras family small GTPasesPoster presentation
- 第28回日本分子生物学会年会, Dec. 2005, English, 日本分子生物学会, 福岡, Domestic conferenceCrystal structure of M-Ras reveals a GTP-bound "off" state conformation of Ras family small GTPasesPoster presentation
- 第64回日本癌学会学術総会, Sep. 2005, English, 日本癌学会, 札幌, Domestic conferenceCrystal structure of M-Ras reveals a GTP-bound "off" state conformation of Ras family small GTPaseOthers
- XX Congress of the International Union of Crystallography, Aug. 2005, English, International Union of Crystallography, フィレンツェ, International conferenceCrystal Structure of the small G protein M-Ras and its implicationsPoster presentation
- 第77回日本生化学会大会, Oct. 2004, English, 日本生化学会, 神戸, Domestic conferenceM-Rasの特異的高次構造とGTPase活性及びエフェクター認識機Poster presentation
- 第26回日本分子生物学会年会, Dec. 2003, English, 日本分子生物学会, 横浜, Domestic conference低分子量GTP結合蛋白質M-RasのX線構造解析Poster presentation
- 国立研究開発法人日本医療研究開発機構, AMED創薬支援ネットワーク委託実験調査, Kobe University, Apr. 2024 - Mar. 2025, Principal investigatorDevelopment of Novel PPI inhibitors as anti-cancer drugs
- 大阪大学医学部付属病院未来医療開発部, 「橋渡し研究推進による」未来医療創出」, 神戸大学, Sep. 2023 - Mar. 2024新規白血病治療薬の開発
- 国立研究開発法人科学技術振興機構, 研究成果展開事業 社会還元加速プログラムSTART大学・エコシステム推進型 大学推進型, 神戸大学, May 2023 - Mar. 2024, Principal investigatorRasシグナルの網羅的阻害を示す革新的がん治療薬の創出を目指した研究
- 国立研究開発法人 日本医療研究開発機構, AMED創薬支援ネットワーク委託実験調査(スクリーニング), Kobe University, Apr. 2022 - Mar. 2024, Principal investigatorDevelopment of Novel PPI inhibitors as anti-cancer drugs
- Japan Society for the Promotion of Science, Grants-in-Aid for Scientific Research Grant-in-Aid for Scientific Research on Innovative Areas (Research in a proposed research area), Grant-in-Aid for Scientific Research on Innovative Areas (Research in a proposed research area), Kobe University, Apr. 2022 - Mar. 2024Elucidation of cancer signal transduction mechanism using photo-controllable Ras on an atomic scale
- 国立研究開発法人科学技術振興機構, 産学が連携した研究開発成果の展開 研究成果展開事業 大学発新産業創出プログラム(START) 大学推進型, 神戸大学, Apr. 2022 - Mar. 2023, Principal investigator本事業の目的は、神戸大学および大阪工業大学において、5年後までに外部資金の間接経費や寄附金を原資とする継続的なGAPファンドやシード投資ファンドを運営・発展させ、継続的な起業活動支援を可能にすることである。 神戸大学と大阪工業大学に所属する研究者の技術シーズに基づく起業活動支援を通じて技術シーズやビジネスモデルのブラッシュアップを行うとともに、「大学発新産業創出プログラム(START)」の申請やベンチャーキャピタル(VC)へ橋渡しする。同時にさらなる技術シーズの創出につなげることで内閣府事業「スタートアップ・エコシステム拠点都市注)」の「グローバル拠点都市」に採択された「京阪神連携によるスタートアップ・エコシステム拠点形成」に貢献する。 具体的には、神戸大学と大阪工業大学が共同でGAPファンドプログラム、起業活動支援プログラムを構築し、試作品製作、追加データ取得などにより、STARTやVCでの評価や投資判断ができるレベルまでビジネスモデルをブラッシュアップする。
- 国立研究開発法人日本医療研究開発機構, Translational Research Program, Kobe University, Apr. 2022 - Mar. 2023Development of novel leukemia therapeutics
- Japan Society for the Promotion of Science, Grants-in-Aid for Scientific Research Grant-in-Aid for Scientific Research on Innovative Areas (Research in a proposed research area), Grant-in-Aid for Scientific Research on Innovative Areas (Research in a proposed research area), Kobe University, Oct. 2020 - Mar. 2022Time-resolved structural analysis of small GTPase Ras signaling transduction by utilizing caged-GTP-coupled Ras protein① NPEcagedGTP・Ras複合体微結晶に加え、光制御下でのcage離脱速度がより速いpHPcagedGTP を用いたSFXを実施しポケット開閉運動初期のデータ収集を行ために、pHPcagedGTPの合成経路の探索を外注(ナード社)において行った。 cagedATP合成に関する文献と同一、もしくは類似のルート、およびいくつかのルーとを探索したが合成の難易度が比較的高いことが明らかになった。中間体の合成方法は見出されたが、中間体からcagedGTPへの縮合反応が上手く進まない状況にある。現在、グアノシンならびにグアノシンモノリン酸をグアノシン側のパーツとしてして用いた新たな合成ルートを検討している。課題採択ならびに研究開始時期が2020年度下期だったこともあり、pHPcagedGTPの入手には至っていない。 ② NPEcaged-GTP型H-Rasの光照射HSQC_NMR測定とアミノ酸残基ごとのkinetics解析により、GTPの加水分解反応(GDP生成反応)において、2つのSwitch領域の構造変化に先駆けて、当該領域に隣接するα3ヘリックスとP-loopの構造変化が起こることが確認できた。また、GTPの加水分解過程においてRasはState 1構造を経由した後GDP型になることが明らかになった。 ③ GTP加水分解反応に際してState 2構造を経由するかどうかについては、構造変化の速度が溶液中と比較して緩やかになることが予想される、NPEcagedGTP型H-Ras微結晶を用いた光照射・固体31P_ NMR測定が必要と考えらえたため、当該測定を実施したこところ、cage離脱後State 1からState 2を経てGDP型への構造変化を示唆する実験データが得られた。 以上の研究成果を2020.12の第43回日本分子生物学会にて発表した(Saeki et al.)。
- 国立研究開発法人日本医療研究開発機構, 橋渡し研究戦略的推進プログラム「異分野融合型研究の推進による自立循環型新規医療創出基盤の確立」, 神戸大学, Apr. 2020 - Mar. 2022Development of novel Ras-signaling inhibitors
- Japan Society for the Promotion of Science, Grants-in-Aid for Scientific Research Grant-in-Aid for Scientific Research (C), Grant-in-Aid for Scientific Research (C), Kobe University, Apr. 2019 - Mar. 2022Atomic-scale dynamic structural analysis of Ras by SACLA, which provide promising information on designing cancer therapeutic agentsSmall GTPase Ras functions as a molecular switch by cycling between GTP-bound active and GDP-bound inactive forms in cell signaling pathways. Despite its importance as a cancer driver gene product, dedicated efforts to directly target Ras for decades still have not yielded therapeutic efficacy, due to limited structural information on natural GTP-bound Ras and its ‘undruggable’ nature of drug-binding site, i.e., structural dynamics hampering stable drug-binding, that is intriguingly linked to its GTP hydrolysis activity. Here to elucidate structural dynamics of natural GTP-bound Ras, we performed time-dependent structural analysis of photo-controllable caged-GTP-bound Ras on GTP hydrolysis process by SACLA, SPring-8 and NMR. Photo-irradiation to caged-GTP-bound Ras yielded natural GTP-bound Ras, leading to GTP hydrolysis for production of Ras-GDP. These results provide new insight into the structural dynamics of Ras, realizing novel strategies for development of Ras inhibitors.
- 国立研究開発法人 日本医療研究開発機構, AMED創薬支援ネットワーク委託実験調査(標的検証・後期), 神戸大学, Dec. 2019 - Mar. 2021, Principal investigatorDevelopment of Novel PPI inhibitors as anti-cancer drugsCompetitive research funding
- 公益財団法人ひょうご科学技術協会, 平成31年度学術研究助成, Apr. 2019 - Mar. 2020, Principal investigator抗がん剤の設計基盤となるX線自由電子レーザーによるRasの時分割構造解析Competitive research funding
- 国立研究開発法人 日本医療研究開発機構, AMED創薬支援ネットワーク委託実験調査, Jul. 2014 - Mar. 2019, Principal investigatorRas/Rafシグナル伝達を阻害する新規抗がん剤の研究Competitive research funding
- 神戸大学医学部第二内科同門会, 神戸大学医学部第二内科同門会助成金, Apr. 2018 - Dec. 2018, Principal investigatorがん転移治療抗体薬開発のためのインテグリンα10の立体構造解析Competitive research funding
- 科学研究費補助金/基盤研究(B), Apr. 2014 - Mar. 2017Competitive research funding
- 科学研究費補助金/基盤研究(B), Apr. 2014 - Mar. 2017, Principal investigatorCompetitive research funding
- 厚生労働科研研究費補助金, Apr. 2011 - Mar. 2016rasがん遺伝子産物の新規立体構造情報に基づくがん分子標的治療薬の開発Competitive research funding
- 高松宮妃癌研究基金研究助成金, Apr. 2014 - Mar. 2015, Principal investigator新規Ras機能阻害物質Kobe0065ファミリー化合物のがん転移抑制メカニズムの解析Competitive research funding
- 公益財団法人ひょうご科学技術協会, 学術研究助成金, Apr. 2013 - Mar. 2014, Principal investigatorrasがん遺伝子産物の立体構造情報を基盤としたがん分子標的治療薬の理論設計Competitive research funding
- 学術研究助成基金助成金/基盤研究(C), Apr. 2011 - Mar. 2014, Principal investigatorCompetitive research funding
- 科学研究費補助金/基盤研究(B), 2011Competitive research funding
- 研究成果最適展開支援プログラム フィージビリティスタディステージ 探索タイプ 拠点型, 2011, Principal investigatorA-STEP「Ras/Rafシグナル伝達を阻害する新規抗がん剤の開発」Competitive research funding
- 科学研究費補助金/基盤研究(C), Apr. 2008 - Mar. 2010, Principal investigatorCompetitive research funding
- 科学研究費補助金/特定領域研究, Apr. 2008 - Mar. 2010, Principal investigatorCompetitive research funding
- 科学研究費補助金/特定領域研究, Apr. 2006 - Mar. 2008, Principal investigatorCompetitive research funding
- 科学研究費補助金/基盤研究(B), 2008Competitive research funding
- 科学研究費補助金/若手研究(B), Apr. 2004 - Mar. 2006, Principal investigatorRas/Rap結合(RA)ドメインによるGTP結合蛋白質認識機構の解明Competitive research funding
- 科学研究費補助金/基盤研究(B), 2005Competitive research funding
- 科学研究費補助金/特定領域研究, 2005Competitive research funding
- 科学研究費補助金/若手研究(B), Apr. 2002 - Mar. 2004, Principal investigatorCompetitive research funding
- Japan Society for the Promotion of Science, Grants-in-Aid for Scientific Research, Grant-in-Aid for Scientific Research (B), Kobe University, 2003 - 2004Analysis of the Regulatory Mechanism and Function of a Novel Class of Phospholipase C, PLCε1, We constructed phospholipase C_ε(PLC_ε) knockout mice and showed that the hearts of these mice develop ventricular dilation, which is caused by a volume overload resulting from marked regurgitation and mild stenosis of the semilunar (aortic and pulmonic) valves. We analysed the mechanism of the congenital semilunar valvulogenesis defect causing these phenotypes and concluded that the abnormal thickening and morphology of the semilunar valve leaflets in PLC_ε knockout mice were caused by aberrant cellular proliferation in valve remodeling at the late stages of semilunar valvulogenesis. By analogy with the phenotypes of mice carrying an attenuated epidermal growth factor (EGF) receptor or deficient in heparin-binding EGF, we speculated a crucial role of PLC_ε, as a Ras effector downstream of the EGF receptor, in inhibition of valvular cell proliferation. In fact, we observed increased phosphorylation of Smad1/5/8, which induce valvular cell proliferation downstream of the BMP receptor, in PLC_ε knockout mice. 2, By applying the two stage skin chemical carcinogenesis protocol using DMBA as an initiator and a phorbor ester TPA as a promoter to PLC_ε knockout mice, we showed that PLC_ε plays a crucial role in ras oncogene-induced development of benign tumors as well as in their malignant progression. We further analysed the mechanism of action of PLC_ε. PLC_ε knockout mice showed marked reduction in proliferation of basal layer cells and epidermal hyperplasia induced by TPA, suggesting a crucial role of PLC_ε in downstream signaling from TPA. 3, We disrupted the PLC_ε gene in a model organism Caenorhabditis elegans and observed a sterile phenotype, caused by abnormal contraction of sphincter muscles of the spermatheca. 4, By using BaF3 cells expressing a PDGF receptor mutant lacking the PLC_γ-binding sites, we showed the importance of PH and RA domains by establishing an assay system for Ca^<2+> increase induced by PDGF-dependent PLC_ε activation.
- Japan Society for the Promotion of Science, Grants-in-Aid for Scientific Research, Grant-in-Aid for Scientific Research (B), Kobe University, 2001 - 2002Analysis of the Function of a Novel Class of Mammalian Phospholipase C, PLCεWe have clarified the regulation mechanism of a novel class of phospholipase C, PLCε, and established PLDε as an effector of small GTPases Ras and Pap1. Also, a physiological function of PlCε has been elucidated. 1. The CDC25 homology domain of PLCε acts as a guanine nucleotide exchange factor for Rap1, thereby amplifying Rap1-dependent signaling. Stimulation of cells by platelet-derived growth factor (PDGF), induces two phase activation of PLCε through activation of Ras and Rap1. The rapid and initial phase of this activation is mediated by Ras at the plasma membrane, whereas Rap1 is responsible for the prolonged activation at the Golgi apparatus. The CDC25 homology domain is crucial for the prolonged activation of PCLε by Rap1. The Ras/Rap1-dependent activation of PLCε prevents BaF3 cells from undergoing apoptosis and sustains their proliferation. 2. Analysis of the spatial and temporal expression patterns of PLCε indicates that in mouse embryos a specific induction of PLCε expression is observed during the course of differentiation of the neural stem cells into the neuronal lineage. In adult, PLCε is expressed abundantly in the heart. The PLCε gene-knockout mice, created by gene targeting, are found to exhibit a phenotype characterized by a market cardiomegaly as well as by overexpression of the heart failure markers as early as 4 weeks of age. Thus, PLCε may play a crucial function in intracellular signaling of the cardiomyocytes by linking the Ras pathway with the Ca^<2+>-calcineurin-NFAT pathway. 3. We have isolated a Caenorhabditis elegans mutant worm lacking the PLCε gene. It exhibits a sterile phenotype due to a disorder in transporting the eggs to the uterus, which is presumably caused by defective relaxation of the sphincters of the spermatheca. It is interesting that both the mammals and the nematodes exhibit a similar phenotype carrying a defect in rhythmic muscular contraction.
- RasRaf binding inhibitors特願2021-125013, 30 Jul. 2021, Kobe UniversityPatent right
- Ras機能阻害作用を有するチオキソチアゾリジン誘導体特願2013-514037, 09 May 2012, 大学長, 特許6014816, 07 Oct. 2016Patent right
- Ras機能阻害作用を有するチオキソチアゾリジン誘導体(アメリカ)14/116152, 09 May 2012, 大学長, US9056862, 16 Jun. 2015Patent right
- THIOXOTHIAZOLIDINE DERIVATIVE HAVING RAS FUNCTION INHIBITORY EFFECT特願WO 2012/153775 A1, 10 May 2011, 特許WO 2012/153775 A1Patent right
- AQUEOUS SOLUTION CONTAING PARTIAL RaS POLYPEPTIDE AND METHOD FOR SCREENING INHIBITOR OF RAS FUNCTION特願WO/2012/108297 A1, 07 Feb. 2011, 特許WO/2012/108297 A1Patent right
- Aqueous Solution Containing Partial Ras Polypeptid and Method for Screening Inhibitor of Ras Function特願WO2012108297A1, 07 Feb. 2011, 特許WO2012108297A1Patent right